For the Inventor, By the Inventor

Enter assignee name

Lawrence, KS, United States of America

Crititech, Inc.

USPTO Granted Patents = 33

EPO Patents = 10

Trademarks = 1

Forward Citations = 260

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Michael Baltezor (21 out of 21 patents)

Matthew McClorey (18 out of 18 patents)

Gere S diZerega (14 out of 15 patents)

4. Joseph S Farthing (13 out of 13 patents)

5. Charles J Decedue (13 out of 14 patents)

6. Sam Campbell (12 out of 14 patents)

7. Mark D Williams (11 out of 12 patents)

8. Jahna Espinosa (9 out of 9 patents)

9. Jacob M Sittenauer (8 out of 8 patents)

10. Bala Subramaniam (7 out of 61 patents)

11. Jake Sittenauer (6 out of 6 patents)

12. Samuel Campbell (6 out of 6 patents)

13. Julia K Fischer (6 out of 6 patents)

14. Gary E Clapp (6 out of 6 patents)

15. Mike Baltezor (5 out of 6 patents)

33 patents: Sort by Forward Citations

1. 12390459 - Methods for solid tumor treatment (2025-08-19),

2. 12329858 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2025-06-17),

3. 12128131 - Treatment of epithelial cysts by intracystic injection of antineoplastic particles (2024-10-29),

4. 12029818 - Lapatinib particles and uses thereof (2024-07-09),

5. 11931368 - Glucocorticoid 'nintedanib' particles and their use (2024-03-19),

6. 11918691 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2024-03-05),

7. 11738029 - Rucaparib particles and uses thereof (2023-08-29),

8. 11738014 - Niraparib particles and uses thereof (2023-08-29),

9. 11737972 - Treatment of epithelial cysts by intracystic injection of antineoplastic particles (2023-08-29),

10. 11583499 - Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer (2023-02-21),

11. 11523983 - Treatment of epithelial cysts by intracystic injection of antineoplastic particles (2022-12-13),

12. 11458133 - Methods for solid tumor treatment (2022-10-04),

13. 11291646 - Nozzle assembly and methods for use (2022-04-05),

14. 11160754 - Methods for treating lung disorders (2021-11-02),

15. 11123322 - Taxane particles and their use (2021-09-21),

CritiTech, Inc. is a cutting-edge technology company specializing in providing innovative solutions for various industries. With a focus on research and development, we aim to deliver advanced products and services that push the boundaries of technology. Our team of talented professionals is passionate about creating groundbreaking solutions to meet the evolving needs of our clients. Visit our website to explore our extensive range of products and learn more about how we can assist your business.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

33 Patents

#4 in Lawrence, KS

#87 in Kansas

#9,947 in US

#19,554 in the World

Lawrence, KS, United States of America

Crititech, Inc.

Forward Citations = 260

30 inventors:

Michael Baltezor (21 out of 21 patents)

Matthew McClorey (18 out of 18 patents)

Gere S diZerega (14 out of 15 patents)

4. Joseph S Farthing (13 out of 13 patents)

5. Charles J Decedue (13 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…